Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly
Pituitary Feb 08, 2018
Chiloiro S, et al. - The effects of somatostatin receptor ligands (SRLs) and pegvisomant (PegV) on the incidence of vertebral fractures (VFs) were examined in patients with acromegaly. They found similar effects of PegV and SRLs on VF risk in acromegaly. The main determinant of VFs was the activity of disease, independent of the drug used to control acromegaly.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
